Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-09-19

Clinical Trial Update: A Study To Investigate Whether PF-04457845 Is Effective In Treating Pain, Is Safe And Tolerable In Patients With Osteoarthritis Of The Knee [Phase 2]

View source ↗

Summary

Phase 2 study evaluating PF-04457845 for pain and safety in knee osteoarthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PF-04457845

Snippet

Sponsor: Pfizer | Conditions: Osteoarthritis, Knee | Phase 2 | Status: COMPLETED